Literature DB >> 10819819

Postoperative morbidity in the morbidly obese parturient woman: supraumbilical and low transverse abdominal approaches.

M C Houston1, B D Raynor.   

Abstract

OBJECTIVE: Our purpose was to determine the differences in postoperative morbidity in obese women who had a supraumbilical or a Pfannenstiel incision at cesarean delivery. STUDY
DESIGN: A case-control retrospective review was conducted of all patients who were at >150% ideal body weight when undergoing cesarean delivery between 1989 and 1995 by means of either a supraumbilical or a Pfannenstiel incision. Patients were excluded if medical records were unavailable. A total of 15 women who had a supraumbilical incision and 54 who had a low transverse incision were included in the analysis. Antenatal complications were examined, as were age, weight, and training level of the surgeon. Postoperative complications were then compared.
RESULTS: The groups were similar in age and antepartum complications. However, mean weight and percentage of ideal body weight in the supraumbilical group were both higher (P <.00001 and P <.0001, respectively), with the supraumbilical group 83 lb heavier on average. No significant differences were seen in any postoperative complication.
CONCLUSION: Postoperative morbidity in morbidly obese women undergoing cesarean delivery does not differ between a supraumbilical approach and the low transverse abdominal incision.

Entities:  

Mesh:

Year:  2000        PMID: 10819819     DOI: 10.1067/mob.2000.105400

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

Review 1.  Techniques for caesarean section.

Authors:  G J Hofmeyr; M Mathai; A Shah; N Novikova
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

2.  Predictors of surgical site skin infection and clinical outcome at caesarean section in the very severely obese: A retrospective cohort study.

Authors:  Michael Dias; Allyn Dick; Rebecca M Reynolds; Marius Lahti-Pulkkinen; Fiona C Denison
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.